AeroLab Institutional Research (AIR) Focused on inhaled therapeutics, innovation, and asymmetric biotech reratings. Covering (MNKD) deep-value, platform-validated, BXLS-aligned midcap in transition. Independent researcher. Not investment advice.
Advertisement|Remove ads.